RichardLafayette Menlo ParkUnited States

• Update on Diabetes Kidney Disease Management
  SunitaBavanandan Speaker sbavanandan@gmail.comMalaysia
• New Drugs for Polycystic Kidney Disease
  MichelChonchol Speaker Michel.Chonchol@comcast.netUnited States
• B Cell Targeted Therapies for Glomerular Diseases
  RichardLafayette Speaker czar@stanford.eduUnited States
• Q&A Session

• A Role for Kidney Resident B/plasma Cells in Kidney Disease Progression?
  HeatherReich Speaker Heather.Reich@uhn.caCanada
• B Cell Activating Factor and A Proliferation-inducing Ligand Signaling in Glomerular Disease
  HongZhang Speaker hongzh@bjmu.edu.cnChina
• B Cell Targeted Therapies in Glomerular Diseases
  RichardLafayette Speaker czar@stanford.eduUnited States
• The Future of B Cell Therapies in the Treatment of Glomerular Diseases
  Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom
• Q&A Session

• Overview of Unmet Need in IgA Nephropathy and Disease Markers
  AdrianLiew Speaker draliew2@gmail.comSingapore
• Emerging Therapeutics Targets in IgAN: The Role of BAFF and APRIL
  SuceenaAlexander Speaker suceena@gmail.comIndia
• Targeting BAFF and APRIL with Atacicept
  RichardLafayette Speaker czar@stanford.eduUnited States